154 related articles for article (PubMed ID: 29895130)
1. Single nucleotide polymorphisms of XRCC3 gene in hepatocellular carcinoma - relationship with clinicopathological features.
Avadanei ER; Giusca SE; Negura L; Caruntu ID
Pol J Pathol; 2018; 69(1):73-81. PubMed ID: 29895130
[TBL] [Abstract][Full Text] [Related]
2. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
[TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population.
Wang PS; Kuai J; Li H; Wang CG; Shi BJ; Zhong L
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):282-8. PubMed ID: 27298104
[TBL] [Abstract][Full Text] [Related]
4. Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort.
Chen JH; Wang YY; Lv WB; Gan Y; Chang W; Tian NN; Huang XH; Liu L; Yu XF; Chen SD
World J Gastroenterol; 2016 Apr; 22(16):4183-90. PubMed ID: 27122668
[TBL] [Abstract][Full Text] [Related]
5. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
6. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
[TBL] [Abstract][Full Text] [Related]
7. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.
Li HG; Liu FF; Zhu HQ; Zhou X; Lu J; Chang H; Hu JH
Int J Clin Exp Pathol; 2015; 8(11):15255-9. PubMed ID: 26823876
[TBL] [Abstract][Full Text] [Related]
9. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
11. Associations of rs1799794 and rs1799796 polymorphisms with risk of breast cancer: A meta-analysis.
Niu H; Yang J; Chen X
J Cancer Res Ther; 2021 Nov; 17(5):1225-1233. PubMed ID: 34850771
[TBL] [Abstract][Full Text] [Related]
12. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
13. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
14. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
15. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
Wang JJ; Wang ZB; Tan TC
Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
18. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract][Full Text] [Related]
19. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.
Long XD; Ma Y; Qu DY; Liu YG; Huang ZQ; Huang YZ; Lin ZH; Wei NB; Zhou SC
Ann Epidemiol; 2008 Jul; 18(7):572-8. PubMed ID: 18504145
[TBL] [Abstract][Full Text] [Related]
20. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
